Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. May 27, 2025; 17(5): 101674
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.101674
Table 1 Comparison of positive methyltransferase-like factor 14 expression between the two groups, n (%)
Group
Number of cases
Positive expression
Negative expression
Tumor tissue8031 (38.75)49 (61.25)
Tissue adjacent to the carcinoma tissue8064 (80.00)16 (20.00)
χ228.217
P value< 0.001
Table 2 Comparison of methyltransferase-like factor 14 expression among patients with different clinicopathologies, n (%)
Clinical pathology data
Positive expression (n = 31)
Negative expression (n = 49)
χ2
P value
Gender0.0240.877
    Male (n = 43)17 (39.53)26 (60.47)
    Female (n = 37)14 (37.84)23 (62.16)
Age (years)0.0790.779
    ≤ 60 (n = 48)18 (37.50)30 (62.50)
    > 60 (n = 32)13 (40.63)19 (59.37)
Tissue typing0.4270.808
    Poorly differentiated (n = 30)13 (43.33)
17 (56.67)
    Moderately differentiated (n = 28)10 (35.71)18 (64.29)
    Well differentiated (n = 22)8 (36.36)14 (63.67)
Tumor location0.0260.872
    Rectal carcinoma (n = 52)20 (38.46)
32 (60.54)
    Carcinoma of colon (n = 28)11 (39.29)17 (60.71)
Tumor diameter (cm)0.0070.935
    ≤ 4 (n = 34)13 (38.24)21 (61.76)
    > 4 (n = 46)18 (39.13)28 (60.87)
Lymphatic metastasis8.9880.003
    Yes (n = 23)3 (13.04)20 (86.96)
    No (n = 57)28 (49.12)29 (50.88)
Infiltration depth12.6030.001
    T1 + T2 (n = 42)24 (57.14)18 (42.86)
    T3 + T4 (n = 38)7 (18.42)31 (81.58)
TNM stage15.3930.001
    I (n = 21)18 (85.71)3 (14.29)
    II (n = 30)10 (33.33)20 (66.67)
    III (n = 29)3 (10.34)26 (89.64)
Table 3 Comparison of methyltransferase-like factor 14 mRNA expression among patients with different clinicopathologies (mean ± SD)
Clinical pathology data
METTL14 mRNA expression
t
P value
Sex1.7240.089
    Male (n = 43)0.13 ± 0.03
    Female (n = 37)0.14 ± 0.02
Age (years)1.2050.232
    ≤ 60 (n = 48)0.12 ± 0.04
    > 60 (n = 32)0.13 ± 0.03
Tissue typing1.2940.280
    Poorly differentiated (n = 30)0.13 ± 0.03
    Moderately differentiated (n = 28)0.12 ± 0.02
    Well differentiated (n = 22)0.12 ± 0.03
Tumor location1.2400.219
    Rectal carcinoma (n = 52)0.14 ± 0.04
    Carcinoma of colon (n = 28)0.13 ± 0.02
Tumor diameter (cm)1.8660.066
    ≤ 4 (n = 34)0.13 ± 0.01
    > 4 (n = 46)0.14 ± 0.03
Lymphatic metastasis5.878< 0.001
    Yes (n = 23)0.10 ± 0.02
    No (n = 57)0.14 ± 0.03
Infiltration depth8.780< 0.001
    T1 + T2 (n = 42)0.16 ± 0.04
    T3 + T4 (n = 38)0.09 ± 0.03
TNM stage43.442< 0.001
    I (n = 21)0.16 ± 0.04
    II (n = 30)0.11 ± 0.03
    III (n = 29)0.08 ± 0.02